Joaquim Ros Salvador
Grau: Doctor/a
973 702 275
joaquim.ros(ELIMINAR)@udl.cat
ResearcherID: http://www.researcherid.com/rid/A-7507-2010
Publicacions
-
Sanz-Alcázar, A; Portillo-Carrasquer, M; Delaspre, F; Pazos-Gil, M; Tamarit, J; Ros, J; Cabiscol, E
Deciphering the ferroptosis pathways in dorsal root ganglia of Friedreich ataxia models. The role of LKB1/AMPK, KEAP1, and GSK3ß in the impairment of the NRF2 response
Redox Biology 76 103339-103339. .
-
Alemany-Perna B; Tamarit J; Cabiscol E; Ros J
Reply to: "Calcitriol in Friedreich Ataxia".
MOVEMENT DISORDERS 39 1654-1655. .
-
Alemany-Perna, B; Tamarit, J; Cabiscol, E; Delaspre, F; Miguela, A; Huertas-Pons, JM; Quiroga-Varela, A; Ruiz, MM; Dominguez, DL; Torrenta, L; Genis, D; Ros, J
Calcitriol Treatment Is Safe and Increases Frataxin Levels in Friedreich Ataxia Patients
MOVEMENT DISORDERS 39 1099-1108. .
-
Sanz-Alcázar A; Britti E; Delaspre F; Medina-Carbonero M; Pazos-Gil M; Tamarit J; Ros J; Cabiscol E
Mitochondrial impairment, decreased sirtuin activity and protein acetylation in dorsal root ganglia in Friedreich Ataxia models.
Cellular And Molecular Life Sciences 81 12-12. .
-
Medina-Carbonero, M; Sanz-Alcazar, A; Britti, E; Delaspre, F; Cabiscol, E; Ros, J; Tamarit, J
Mice harboring the FXN I151F pathological point mutation present decreased frataxin levels, a Friedreich ataxia-like phenotype, and mitochondrial alterations.
Cellular And Molecular Life Sciences 79 74-74. .
-
Tamarit J; Britti E; Delaspre F; Medina-Carbonero M; Sanz-Alcázar A; Cabiscol E; Ros J
Mitochondrial iron and calcium homeostasis in Friedreich ataxia.
IUBMB LIFE 73 543-553. .
-
Britti E; Delaspre F; Sanz A; Medina-Carbonero M; Llovera M; Purroy R; Mincheva-Tasheva S; Tamarit J; Ros J
Calcitriol increases frataxin levels and restores mitochondrial function in cell models of Friedreich Ataxia.
BIOCHEMICAL JOURNAL 478 1-20. .
-
Britti, E; Delaspre, F; Tamarit, J; Ros, J
Calpain-Inhibitors Protect Frataxin-Deficient Dorsal Root Ganglia Neurons from Loss of Mitochondrial Na + /Ca 2+ Exchanger, NCLX, and Apoptosis.
NEUROCHEMICAL RESEARCH 46 108-119. .
-
Rodríguez-Pascau L; Britti E; Calap-Quintana P; Dong YN; Vergara C; Delaspre F; Medina M; Tamarit J; Pallardó FV; Gonzalez-Cabo P; Ros J; Lynch DR; Martinell M; Pizcueta P
PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia.
NEUROBIOLOGY OF DISEASE 148 105162-105162. .
-
Rodríguez Colman MJ; Ros J; Cabiscol E
Mitochondrial Localization of the Yeast Forkhead Factor Hcm1.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 21 -. .
-
Purroy, R; Medina-Carbonero, M; Ros, J; Tamarit, J
Frataxin-deficient cardiomyocytes present an altered thiol-redox state which targets actin and pyruvate dehydrogenase.
Redox Biology 32 101520-101520. .
-
Britti, E; Ros, J; Esteras, N; Abramov, AY
Tau inhibits mitochondrial calcium efflux and makes neurons vulnerable to calcium-induced cell death.
Cell Calcium 86 102150-102150. .
Projectes
- Uncovering the function of a conserved site in eukaryotic frataxins.
- Desarrollo de la leriglitazona para el Síndrome de Rett y trastornos relacionados
- Mecanismos de disfuncion mitocondrial y nuevas estrategias terapéuticas en modelos celulares y animales de Ataxia de Friedreich
- Nuevo fármaco dirigido a la Ataxia de Friedreich
- MithrAtaxia: Validació en laboratori dels efects protectors de mithramycin A por un us terapeutic en Ataxia de Friedreich
- Targeting mitochondria in Friedreich Ataxia: molecular mechanisms and therapeutic approaches
- Búsqueda de nuevas indicaciones terapéuticas en el ámbito de enfermedades neurodegenerativas y mitocondriales para el compuesto PPAR gamma agonista MIN-102
- Effect of vitamin D in frataxin-deficient DRG neurons from rat and iPS cells obtained from FA patients
- MODELOS CELULARES DE ATAXIA DE FRIEDREICH: BASES MOLECULARES DE LA PATOLOGIA E IDENTIFICACION DE BIOMARCADORES Y COMPUESTOS CON POTENCIAL TERAPEUTICO
- Modelos celulares de ataxia de Friedreich: bases moleculares de la patología e identificación de biomarcadores y compuestos con potencial terapéutico
- PATHOPHYSIOLOGY AND THERAPEUTICS OF FRIENDREICH ATAXIA: MARKERS OR OXIDATIVE STRESS FROM YEAST TO CARDIOMYOCYTES
- Análisis proteómico y funcional de los efectos del estrés oxidativo y la desregulación de la homeostasis del hierro en modelos celulares de ataxia de Friedreich